Using Erythropoietin for a Jehovah's Witness During Surgery and Chemotherapy
Author Information
Author(s): P.W.M. Johnson, R. King, M.L. Slevin, H. White
Primary Institution: ICRF Department of Medical Oncology, St Bartholomew's and Homerton Hospitals
Hypothesis
Can erythropoietin help maintain hemoglobin levels in patients who cannot receive blood transfusions?
Conclusion
Erythropoietin effectively maintained hemoglobin levels in a Jehovah's Witness patient undergoing major surgery and chemotherapy without blood transfusions.
Supporting Evidence
- Erythropoietin was started on the 4th post-operative day and hemoglobin rose at a rate of 1 g/dl every 4 days.
- The patient maintained hemoglobin levels above 9.5 g/dl throughout chemotherapy.
- Histology revealed a primary extragonadal yolk-sac tumor instead of sarcoma.
Takeaway
A man who couldn't get blood transfusions due to his beliefs was able to recover from surgery and chemotherapy thanks to a medicine called erythropoietin that helped keep his blood levels normal.
Methodology
Case report detailing the use of erythropoietin and monitoring of hemoglobin levels during surgery and chemotherapy.
Potential Biases
Potential bias due to the unique circumstances of the patient and lack of control group.
Limitations
Only one case is reported, limiting generalizability.
Participant Demographics
36-year-old male Jehovah's Witness.
Want to read the original?
Access the complete publication on the publisher's website